- Home
- TAK vs AJG Comparison
TAK vs AJG Comparison
Compare TAK & AJG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAK | AJG |
|---|---|---|
| Founded | 1781 | 1927 |
| Country | Japan | United States |
| Employees | 47455 | 706000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5B | 57.9B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | TAK | AJG |
|---|---|---|
| Price | $18.14 | $211.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $281.85 |
| AVG Volume (30 Days) | ★ 2.3M | 2.2M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 2.97% | 1.35% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.74 |
| Revenue | N/A | ★ $6,159,600,000.00 |
| Revenue This Year | $0.04 | $31.41 |
| Revenue Next Year | $0.92 | $9.63 |
| P/E Ratio | $41.25 | ★ $36.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.99 | $195.00 |
| 52 Week High | $18.82 | $351.23 |
Technical Indicators
Market Signals| Indicator | TAK | AJG |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 39.57 |
| Support Level | $17.51 | $195.00 |
| Resistance Level | $18.82 | $231.10 |
| Average True Range (ATR) | 0.24 | 5.92 |
| MACD | -0.12 | -0.56 |
| Stochastic Oscillator | 47.22 | 28.92 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About AJG Arthur J. Gallagher & Co.
Founded in 1927 as a one-person agency, Gallagher's primary business is insurance brokerage, with a focus on serving middle-market companies. The company's risk management segment provides third-party claims adjustment to companies that choose to self-insure. Gallagher has about 56,000 employees and generates about a third of its revenue internationally, primarily in Australia, Canada, New Zealand, and the UK.